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Abstract
Background: Maintaining the correct balance of proliferation versus differentiation in retinal
progenitor cells (RPCs) is essential for proper development of the retina. The cell cycle regulator
cyclin D1 is expressed in RPCs, and mice with a targeted null allele at the cyclin D1 locus (Ccnd1-/
-) have microphthalmia and hypocellular retinas, the latter phenotype attributed to reduced RPC
proliferation and increased photoreceptor cell death during the postnatal period. How cyclin D1
influences RPC behavior, especially during the embryonic period, is unclear.
Results: In this study, we show that embryonic RPCs lacking cyclin D1 progress through the cell
cycle at a slower rate and exit the cell cycle at a faster rate. Consistent with enhanced cell cycle
exit, the relative proportions of cell types born in the embryonic period, such as retinal ganglion
cells and photoreceptor cells, are increased. Unexpectedly, cyclin D1 deficiency decreases the
proportions of other early born retinal neurons, namely horizontal cells and specific amacrine cell
types. We also found that the laminar positioning of horizontal cells and other cell types is altered
in the absence of cyclin D1. Genetically replacing cyclin D1 with cyclin D2 is not efficient at
correcting the phenotypes due to the cyclin D1 deficiency, which suggests the D-cyclins are not
fully redundant. Replacement with cyclin E or inactivation of cyclin-dependent kinase inhibitor
p27Kip1 restores the balance of RPCs and retinal cell types to more normal distributions, which
suggests that regulation of the retinoblastoma pathway is an important function for cyclin D1 during
embryonic retinal development.
Conclusion: Our findings show that cyclin D1 has important roles in RPC cell cycle regulation and
retinal histogenesis. The reduction in the RPC population due to a longer cell cycle time and to an
enhanced rate of cell cycle exit are likely to be the primary factors driving retinal hypocellularity
and altered output of precursor populations in the embryonic Ccnd1-/- retina.
Background
The vertebrate retina is composed of seven major cell
classes that arise from a common source, the retinal pro-
genitor cell (RPC) population. Although RPCs at any
given stage are largely multipotential, they are constrained
such that each cell class is generated in a temporal, albeit
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overlapping order. Production of retinal ganglion cells
(RGCs), horizontal cells, and cone photoreceptors is initi-
ated at the earliest stage of retinal neurogenesis, followed
by amacrine cells and rod photoreceptors, which is then
followed by bipolar cells and Müller glia. The relative pro-
portion of cells in each class differs widely. For example,
cones account for approximately 3% and rods approxi-
mately 97% of the photoreceptors in the mouse retina,
and rod photoreceptors are the most abundant cell class
accounting for approximately 70% of all retinal cells [1].
In general, the early-born cell classes constitute a much
smaller percentage of the retina than do the late-born cell
classes [1,3]. While cell death contributes to the final cell
distribution of the adult retina [4,6], the initial allocation
of precursor cells (that is, RPCs that exit the cell cycle) to
each class is a predominant factor in setting their relative
proportions.
In addition to generating the different cell classes, RPCs
need to proliferate in order to produce enough cells to
populate the retina. In the rat retina, RPC proliferation
drives an approximately 400-fold expansion of total cell
number in a 17-day period between embryonic day (E)14
and postnatal day (P)8 [7]. This interval also corresponds
to when the bulk of the RPC population exits the cell cycle
to generate precursors [2]. Thus, RPCs are exposed to com-
peting forces that either influence them to stay in the cell
cycle in order to produce enough cells or to exit the cell
cycle at the appropriate time in order to generate the cor-
rect proportion of cells corresponding to each cell class.
It is generally accepted that multiple cell-extrinsic and -
intrinsic factors play important roles in establishing the
correct balance between RPC proliferation and precursor
generation during development [8-10]. While it is impor-
tant to understand how these different factors are inte-
grated into networks, an understanding of the molecular
mechanisms used to exit the cell cycle during the transi-
tion from RPC to precursor is also needed.
D-type cyclins promote progression from G1 to S phase in
dividing cells by activating cyclin-dependent kinases 4 or
6 (CDK4/6) and by sequestering cyclin-dependent kinase
inhibitors such as cyclin-dependent kinase inhibitor 1B
(CDKN1B, henceforth referred to as P27KIP1) [11]. The
net result is enhanced CDK2 activity, inactivation of retin-
oblastoma proteins, and activation of DNA replication. D-
cyclins are also downstream of various signaling pathways
and, thus, are well positioned to co-ordinate cell cycle
progression with the extracellular environment [11,12].
Mice have three D-cyclin genes: cyclin D1 (Ccnd1), cyclin
D2 (Ccnd2) and cyclin D3 (Ccnd3). The expression and
requirement of the D-cyclins during development is tissue
specific [13]. Surprisingly, mouse embryos lacking all
three D-cyclins develop until E16.5, when they die due to
heart abnormalities combined with severe anemia [14].
Although developmental defects are apparent in these
mice prior to E16.5, proliferation of many tissues, includ-
ing the retina, still occurs, indicating that the D-cyclins are
not absolutely required for cell cycle progression.
Ccnd1 is the predominant D-cyclin in the developing ret-
ina and is highly expressed in RPCs but absent from exited
precursors and differentiated cells [15,18] (this study).
Zebrafish embryos treated with a Ccnd1  morpholino
exhibit small eye [19] and mice lacking Ccnd1 have small
eyes and hypocellular retinas due to reduced RPC prolifer-
ation and postnatal retinal cell death [17,20,21]. How-
ever, the impact of Ccnd1  on embryonic retinal
development has not been directly assessed.
In this study, we characterized the embryonic retinal phe-
notype in Ccnd1-/- mice. We found that the cell cycle rate
of the Ccnd1-/- RPC population is slower than normal and
this population undergoes a faster rate of depletion due to
an increased rate of cell cycle exit. Consistent with this,
RGCs and photoreceptors are overrepresented. Surpris-
ingly, other early-born embryonic cell classes in the retina,
namely horizontal and amacrine cells, are underrepre-
sented in the absence of Ccnd1. Analysis of retinas from
newborn mice in which Ccnd1 is replaced by Ccnd2 reveal
that the proportions of at least some cell types remain
altered, suggesting a unique requirement for Ccnd1  in
RPCs. We also analyzed the retinas of newborn mice in
which Ccnd1 is replaced by human Cyclin E (hCcne) or in
Ccnd1-/-, p27Kip1-/- double mutants and found that the
proportions of cell types approach a more normal distri-
bution. These findings led us to propose that Ccnd1 con-
trols the timing of cell cycle exit in embryonic RPCs and,
by doing so, contributes to the appropriate allocation of
precursor cells to each cell class. We also propose that
Ccnd1 contributes to the correct proliferative expansion of
the retina by influencing the time it takes for RPCs to tran-
sit through the cell cycle and by maintaining a sufficient
number of RPCs during the period of neurogenesis.
Materials and methods
Animals
Ccnd1-/- mice were purchased from Jackson Laboratories
(Bar Harbor, ME, USA). Drs Matthew Fero and James Rob-
erts (Fred Hutchinson Cancer Center, Seattle, WA) kindly
provided the p27Kip1-/- mice. The mouse strains contain-
ing the Ccnd2 cDNA targeted to the Ccnd1 locus (Ccnd1D2/
D2) and human Ccne cDNA targeted to the Ccnd1 locus
(Ccnd1hE/hE) were maintained in the Sicinski laboratory.
The noon of the day a vaginal plug was observed was des-
ignated E0.5. Genotyping was done as previously
described [17,22-24]. All animal use and care was con-
ducted in accordance with protocols approved by the Uni-
versity of Utah Institutional Animal Care and UseNeural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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Committee and set forth in the Association for Research in
Vision and Ophthalmology (ARVO) Statement for the
Use of Animals. Efforts were made to minimize discom-
fort to animals and, when possible, the number of ani-
mals needed per analysis was kept to a minimum.
Immunohistochemistry
Tissue preparation and immunohistochemistry were done
as previously described [25]. Radial cryosections through
the retina were cut at a thickness of 10 m. Primary anti-
bodies are listed in Table 1. Antigen unmasking (0.18 mM
citric acid, 77 M sodium citrate, pH 6.0, 15 minutes, 90–
95°C) was performed prior to incubation with the prolif-
erating cell nuclear antigen (PCNA) antibody. Hydrochlo-
ric acid treatment (2N HCl, 30 minutes, room
temperature) was performed prior to incubation with the
bromodeoxyuridine (BrdU) antibody.
Image analysis
Sections were analyzed by epi-fluorescence using a Nikon
E-600 microscope and images captured in gray scale mode
with a Spot-RT slider CCD camera (Diagnostic Instru-
ments, Sterling Heights, MI, USA). Confocal images were
scanned using an Olympus Fluoview 1000 microscope.
Color (RGB) images were assembled from individual
monochrome channels using Photoshop CS (Adobe Sys-
tems Inc., San Jose, CA, USA). The levels function was
used to adjust the digital images to be consistent with vis-
ual observations.
Marker quantification and statistical analysis
The relative proportions, lineal densities, or areal densi-
ties of marker-positive (+) or -negative (-) cells were quan-
tified at E12, E14.5 and P0. For each genotype, a
minimum of three animals from at least two litters was
sampled. For each animal, three different non-adjacent
central-retina sections were used for cell counting.
At E12, epi-fluorescence images of whole retinal sections
were captured. Cell populations were quantified over the
total area of the sections (marker+ cells/mm2 retina). The
exception was for PCNA+ cells, which were quantified as a
percentage of the total cell population ((PCNA+ cells/
DAPI+ cells) × 100). PCNA+ population was sampled from
the dorsal retina, where neurogenesis initiates. At E14.5,
marker+ cells were calculated as a percentage of total cells
(marker+ cells/DAPI+ cells) from 400×-magnified confocal
images (1,600 × 1,600 resolution), captured at compara-
ble dorsal-medial regions. At P0, marker+ cells were quan-
tified as a percentage of total cells from confocal images of
medial-central retina, within 200 m of the optic nerve
head. Neurofilament medium (NEFM)+ horizontal and
SRY-box containing gene 2 (SOX2)+ amacrine cells were
quantified as a ratio of the unit length of apical surface of
the retina (marker+  cells/mm retina) because of their
sparse, linear distribution. The entire peripheral-central-
peripheral extent of individual sections was used for these
measurements. All cell counts, area, and length measure-
ments were done using Adobe Photoshop CS and ImageJ
(NIH). Students' t-test was performed using Kaleidagraph
statistical and graphing software (Synergy Software, Read-
ing, PA, USA) to determine statistical significance in the
marker+ cell population between mutant and control sam-
ples. In all graphs, numbers inside bars indicate the
number of samples analyzed. Error bars indicate standard
deviation.
Window-labeling using thymidine analogs to measure cell 
cycle times
Retinas with lens attached were cultured for 2.5 hours and
sequentially exposed to two thymidine analogs for
defined intervals. At P0, 5-iodo-2'-deoxy-uridine (IdU)
was added to the culture medium for the first 2 hours and
replaced with 5-bromo-2'-deoxy-uridine (BrdU) for the
final 30 minutes. At E14.5, BrdU was added to the culture
medium for the first 2 hours and replaced with 5-ethynyl-
2'-deoxy-uridine (EdU) for the final 30 minutes. As previ-
ously described [26-28], a combination of mouse anti-
BrdU (clone B44; BD Biosciences, San Jose, CA, USA) and
rat anti-BrdU (clone BU1/75; Serotec, Raleigh, NC, USA)
were used to detect the analogs at P0. For the E14.5 sam-
ples, the mouse anti-BrdU antibody was used to detect
BrdU (EdU is also detected), and EdU was specifically
detected using the Click-it Reaction (Molecular Probes,
Carlsbad, CA, USA) [29]. PCNA was used at both ages to
identify RPCs in all phases of the cell cycle [15]. The
length of the cell cycle (Tc) in hours was calculated by the
formulae:
or
and the length of the S-phase (Ts) in hours was calculated
by the formulae:
or
At E14.5 cell counts were done from a single central field
on each section (at least three sections per animal), gener-
ally on the same side. At P0, cell counts were done on six
fields spanning an entire section (at least of two sections
per animal). Dorsal-ventral orientation was lost upon dis-
() [ ] T  h PCNA  cells/IdU  only cells  at P c =×
++ 20
() [ ] T  h PCNA  cells/BrdU  only cells  at E14.5 c =×
++ 2
() [ ] T  h BrdU  cells/IdU  only cells  at P0 s =×
++ 2
() [ ] T  h EdU  cells/BrdU  only cells  at E14.5 s =×
++ 2Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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secting eyes out. A more detailed analysis of this assay will
appear in a forthcoming manuscript (GD and EML).
Cell cycle exit assay and RGC birthdating
Pregnant mice were injected once with a dose of BrdU (10
mg/ml stock in 0.1 M Tris (pH 7): 100 g/gm of body
weight injected) at E13.5 or E18.5 and sacrificed 24 hours
later at E14.5 and P0.5, respectively. Sections were co-
labeled with antibodies against BrdU and PCNA and
imaged by confocal microscopy. The cell cycle exit index
was calculated as the percentage of BrdU+ cells that were
PCNA- ((BrdU+, PCNA- cells/Total BrdU+ cells) × 100).
To measure the production of RGCs from RPCs, sections
from the same animals used for the cell cycle exit index
were co-labeled with antibodies against BrdU and POU
domain, class 4, transcription factor 2 (POU4F2; formerly
BRN3B). The index for RGC production was calculated as
the percentage of BrdU+ cells that were POU4F2+ ((BrdU+,
POU4F2+ cells/Total BrdU+ cells) × 100). Cell counts were
done from a single dorsal-central field per section (at least
two sections per animal) retina at E14.5. For P0 samples,
counts were done from two peripheral fields at opposite
ends per section (at least two sections per animal).
Results
CCND1 expression pattern during the early stages of 
retinal development
In the mouse retina, CCND1 protein is expressed as early
as E11 [17]. However, a systematic analysis of its expres-
sion pattern during early retinal development has not
been done. Therefore, we examined CCND1 expression
from E9.5 to E14.5, the period of optic cup formation and
onset of retinal neurogenesis (Figure 1). CCND1 protein
is expressed as early as E9.5 in several tissues that give rise
to the eye, including the optic vesicle and surface ecto-
derm, as well as in the adjacent diencephalic neuroepithe-
lium (Figure 1A). At E11, CCND1 expression is strongest
in the central region of the neural retina and in the lens
vesicle (Figure 1B), and the high level of CCND1 expres-
sion in the neural retina spreads outward by E12 and
reaches the peripheral retina by approximately E14.5 (Fig-
ure 1C, D). This dynamic pattern is reminiscent of the
wave of neurogenesis. To examine this relationship fur-
ther, these sections were also labeled with the Tuj1 anti-
body (Figure 1E–H), which detects the acetylated form of
class III beta-Tubulin (acTUBB3) and reveals the initial
formation of the differentiated cell layer (DCL) [30,31]. A
direct comparison of the CCND1 (dashed lines) and
acTUBB3 expression patterns (Figure 1I–L) indicates that
the high level of CCND1 expression in the neuroblast
Table 1: Primary antibodies
Antigen Host Target (relevant to this study) Dilution factor Source
BHLHB5 Goat amacrine precursors1 1000 Santa Cruz (sc-6045)
BrdU Mouse cells that have uptaken BrdU in S-phase 100 BD biosciences (clone B44)
BrdU Rat cells that have uptaken BrdU in S-phase 50-200 Serotec (clone BU1/75)
POU4F2 Goat RGC precursors 50 Santa Cruz (sc-6026)
CASPASE-3 Rabbit dying cells 500 BD biosciences (clone C92-605)
VSX2 Sheep RPCs 400 Exalpha Biologicals (X1180P)
CCND1 Rabbit RPCs 400 Lab Vision (RB-212)
CCND1 Mouse RPCs 400 Santa Cruz (clone 72-13G)
ISL1 Mouse amacrine cells 1 and RGCs 1 50 DSHB (clone 39.4D5)
HES1 Rabbit RPCs 800 Nadean Brown
MITF Mouse RPE 500 Exalpha Biologicals (clone C5)
NEFM Rabbit RGC and horizontal cells 1000 Chemicon (AB1987)
NR2E3 Rabbit rod precursors 100 Anand Swaroop
OTX2 Rabbit photoreceptor and amacrine precursors1 1000 Chemicon (AB9566)
OTX2 Goat photoreceptor and amacrine precursors1 400 Santa Cruz (sc-30659)
PAX6 Mouse RPCs 10 DSHB (clone P3U1)
PCNA Mouse RPCs 500 DAKO (clone PC10)
PCNA Rabbit RPCs 100 Santa Cruz (sc-7907)
pHH3 Rabbit mitotic cells 500 Upstate Biotechnology (06-570)
PTF1A Rabbit amacrine1 and horizontal precursors 800 Helena Edlund
RCVRN Rabbit photoreceptor cells 4000 Chemicon (AB5585)
RXR Rabbit cone and RGC precursors 200 Santa Cruz (sc-555)
SOX2 Rabbit RPCs and amacrine cells 1 400 Abcam (ab15830)
acTUBB3 Rabbit neuronal precursors 4000 Covance (PRB-435P)
acTUBB3 Mouse neuronal precursors 1000 Covance (clone TUJ1)
1marks a subset of cells in this classNeural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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layer (NBL) precedes the wave of acTUBB3 expression, but
their relative timing and similar patterns suggest they are
linked.
Patterning and apoptosis are unaltered by Ccnd1 
inactivation at embryonic ages
Since Ccnd1 is expressed during optic cup formation, the
hypocellularity of the Ccnd1-/- retina could be due to
altered regional patterning. However, analysis of several
markers of optic vesicle and cup patterning did not reveal
differences in the establishment or size of the neural reti-
nal domain (Additional file 1). Likewise, we did not
observe obvious differences in apoptosis at any of the
embryonic ages analyzed as revealed by activated caspase
3 (CASP3) immunoreactivity (Additional file 2) or by
TUNEL assay (data not shown).
Cell cycle time is longer in the Ccnd1-/- RPC population
Having ruled out major changes in retinal domain forma-
tion and cell death, we measured other parameters that
could cause the hypocellularity observed in the Ccnd1-/-
retina. At birth, Ccnd1-/- retinas show a three-fold decrease
in total cells and a concomitant three-fold decrease in cells
that incorporate tritiated thymidine [21]. While these
findings suggest reduced RPC proliferation prior to P0, we
directly analyzed proliferative activity during the embry-
onic period, first by detection of phosphorylated histone
H3 (pHH3), a marker of RPCs in M-phase (Additional file
3) [15]. Fewer pHH3+ cells are evident by E14.5, confirm-
ing that RPC proliferation is reduced in the embryonic
Ccnd1-/- retina.
To get an estimate of the cell cycle time and related meas-
ures, we adapted a window-labeling paradigm that uti-
lizes two thymidine analogs that can be differentially
detected [27] (manuscript in preparation). Frozen sec-
tions from P0 retinas were triple-labeled with a mouse
anti-BrdU antibody identifying both IdU and BrdU (Fig-
ure 2A, D), a rat anti-BrdU antibody identifying only BrdU
(Figure 2B, E) and an anti-PCNA antibody for labeling the
complete RPC cohort (Figure 2C, F) [15]. BrdU and EdU
on E14.5 sections were detected as described (see Materi-
als and methods).
Expression patterns of CCND1 and acTUBB3 during early retinal development Figure 1
Expression patterns of CCND1 and acTUBB3 during early retinal development. Wild-type retinas were double-
labeled with antibodies against (A-D) CCND1 and (E-H) acTUBB3. (I-L) Merged images. Dashed lines indicate the peripheral 
extent of strong CCND1+ cells in retinas from E11 (B, F, J), E12 (C, G, K), and E14.5 (D, H, L) embryos. Asterisks in (A, E, I) 
indicate that this region of the neuroepithelium is folded over in the section. Abbreviations: D, diencephalon; DCL, differenti-
ated cell layer; L, lens; NBL, neuroblast layer; NR, neural retina; OV, optic vesicle; PNR, presumptive neural retina; SE, surface 
ectoderm. Scale bars: 100 m; (K) is representative for (A-C, E-G, I-K); (L) is representative for (D, H, L).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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We observed that the cell cycle time (Tc) of the Ccnd1-/-
RPC population was increased relative to that of the wild-
type RPC population at E14.5 and P0 (Figure 2G).
Although S phase time (Ts) did not vary between the two
genotypes at E14.5, there was a decrease in Ts for the
Ccnd1-/- RPC population at P0 (Figure 2G). We then sub-
tracted the S-phase time from cell cycle time (Tc - Ts),
which yields an estimate of the cumulative time spent in
G1, G2, and M phases, and found that the Tc - Ts value of
the  Ccnd1-/-  RPC population is significantly increased
compared to the wild-type RPC population at both ages
(Figure 2G). Since the function of Ccnd1 in the cell cycle
Retinal progenitor cell (RPC) cell cycle is lengthened in the Ccnd1-/- retina Figure 2
Retinal progenitor cell (RPC) cell cycle is lengthened in the Ccnd1-/- retina. P0 wild-type and Ccnd1-/- retinas, cultured 
successively in iododeoxyuridine (IdU) for 2 hours and bromodeoxyuridine (BrdU) for 30 minutes, were triple-stained with 
mouse (A, D) anti-BrdU antibody (Ab) recognizing both IdU and BrdU, (B, E) rat anti-BrdU antibody recognizing only BrdU, 
and (C, F) with an antibody against PCNA marking RPCs. Arrows in (A-C) mark IdU+ only RPCs (IdU+, BrdU-; positive signal 
in (A, C) but not (B)) in wild-type retina that have moved up to the apical surface during the labeling period. Arrows in (D-F) 
mark IdU+ only RPCs (positive signal in (D, F) but not (E)) in the Ccnd1-/- retina during the same period. (G) Quantification of 
average RPC cell cycle time (Tc), S phase time (Ts) and G1 + G2 + M phase time (Tc - Ts) in wild-type (wt) and Ccnd1-/- retinas 
at E14.5 and P0. Scale bar: 50 m; (F) is representative for (A-F).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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is thought to be specific to the G1 phase, this suggested
that the increase in Tc was due to a longer G1 phase,
although we cannot exclude potential changes in G2 or M
phases. In sum, these findings demonstrate that Ccnd1 is
required to ensure an appropriate rate of passage through
the cell cycle and that the slower rate of proliferation in
the absence of Ccnd1 is likely to contribute to the hypocel-
lularity of the Ccnd1-/-retina.
Increased cell cycle exit in the Ccnd1-/- retina reduces the 
relative size of the RPC population
In addition to a slower cell cycle rate, a reduction in size
of the RPC population due to enhanced cell cycle exit
could also contribute to the proliferation problems asso-
ciated with the hypocellularity of the Ccnd1-/- retina. To
assess this, we first examined the expression pattern of
PCNA and measured the proportion of PCNA+ cells rela-
tive to the total cell population at E12, E14.5 and P0 (Fig-
ure 3A–G). PCNA is expressed in the vast majority of RPCs
during development [15] and its expression characteristics
are not altered relative to other RPC markers in the Ccnd1-
/- retina (Additional file 4). While the distribution of
PCNA+ cells appears unchanged at E12 (Figure 3A, D), the
NBL is visibly thinner in the Ccnd1-/- retina at E14.5 (Fig-
ure 3B, E) and this is confirmed upon quantification (Fig-
ure 3G). At this stage, the thinning of the NBL layer occurs
at the expense of the DCL. At P0, the thinning of the NBL
is more pronounced (Figure 3C, F) and the proportion of
PCNA+ cells is reduced further (Figure 3G). In contrast to
E14.5, a gap in PCNA immunoreactivity is observed at the
apical side of the retina (brackets in Figure 3F), which is
filled by orthodenticle homolog 2 (OTX2)+ cells (Addi-
tional file 5A–F), indicating that these cells are predomi-
nantly post-mitotic photoreceptor precursors (see below).
A similar pattern of PCNA and OTX2 expression was
observed at E17.5 (data not shown).
These observations suggest that RPCs in the Ccnd1-/- retina
are exiting the cell cycle at a comparably more rapid rate
than normal. To assess this more directly, a cell cycle exit
index was measured for the interval between E13.5 to
E14.5, when RPC proliferation is robust and neurogenesis
is well underway, and later between E18.5 and P0.5 (Fig-
ure 3H–O; see Materials and methods). We observed that
a significantly greater proportion of BrdU+ RPCs exit the
cell cycle in the Ccnd1-/- retina compared to wild type at
both ages (Figure 3O), thereby indicating that increased
cell cycle exit is a primary cause for the reduction in RPCs
and is also a contributing factor in causing the hypocellu-
larity observed by birth in the Ccnd1-/- retina.
Enhanced cell cycle exit in the Ccnd1-/- retina leads to 
increased proportions of RGCs and photoreceptors, but 
not an earlier onset of neurogenesis
Enhanced cell cycle exit can lead to two non-mutually
exclusive changes in neurogenesis: an earlier onset or
enhanced neuron production from prematurely exiting
RPCs after onset. Importantly, either change could
increase the proportions of early born neuronal popula-
tions such as RGCs. To determine if neurogenesis initiates
earlier than normal in the Ccnd1-/- retina, we examined the
expression of acTUBB3 and the transcription factor
POU4F2, a marker of RGC precursors [32,33]. Cells posi-
tive for either marker were not observed at E11 or earlier
regardless of genotype (data not shown; Figure 4A, E).
Therefore, it is not likely that neurogenesis initiates early
in the Ccnd1-/- retina.
To determine whether Ccnd1  inactivation increases the
proportion of early-born neurons, we examined the
expression pattern of POU4F2 after the onset of neuro-
genesis (Figure 4B–D, F–H) and measured the percentage
of POU4F2+ cells relative to the total cell population at
E12, E14.5, and P0 (Figure 4I). Although the spatial pat-
terns of POU4F2+ cells in the Ccnd1-/- retina are similar to
wild type at E12 (Figure 4B, F) and E14.5 (Figure 4C, G),
their relative proportions are significantly higher in the
mutant at these ages and at P0 (Figure 4J). Additionally,
most wild-type RGCs are located below the inner plexi-
form layer (IPL; Figure 4D) at P0, but the mutant has an
extra layer of POU4F2+ cells positioned on the apical side
of the IPL (Figure 4H, arrows). A similar pattern of mislo-
calized POU4F2+ cells was also observed at E17.5 (data
not shown).
To confirm that the greater proportion of RGCs is corre-
lated with enhanced RPC cell cycle exit, we directly meas-
ured the proportion of RPCs that were becoming
POU4F2+ RGCs in a given time period. Using the same
samples as for the cell cycle exit assay described above, we
calculated the percentage of BrdU+  cells that express
POU4F2+. By this approach, we found that a significantly
higher percentage of BrdU+ RPCs exit the cell cycle and
form RGCs in the Ccnd1-/- retina from E13.5 to E14.5 (Fig-
ure 4J), confirming that enhanced cell cycle exit of Ccnd1-
/- RPCs leads to increased proportions of early born neu-
rons.
As described above, the apical 'gap' of PCNA expression in
the Ccnd1-/- retina is filled with OTX2+ cells (Additional
file 5D–F). Since OTX2+ cells include both cone and rod
precursors, we examined the P0 expression patterns of
retinoid × receptor gamma (RXR) and nuclear receptor
subfamily 2, group E, member 3 (NR2E3), which mark
cone and rod precursors respectively [34-36]. Consistent
with the increase in OTX2+ cells, the proportions of RXR+Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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cells (Figure 5A, D, G) and NR2E3+ cells (Figure 5B, E, H)
are increased in the Ccnd1-/- retina. The increased propor-
tion of photoreceptors is confirmed by the expression of
recoverin (RCVRN; Figure 5C, F, I), a calcium-binding
protein expressed in photoreceptors at perinatal ages [37].
Further, an apparent increase in cells expressing blue cone
opsin (OPN1SW) at P0 and rhodopsin at P4 (data not
shown) support our conclusion that cones and rods con-
tribute to the relative increase in photoreceptor produc-
tion.
Gradual depletion of retinal progenitor cell (RPC) population in the Ccnd1-/- retina is caused by enhanced cell cycle exit Figure 3
Gradual depletion of retinal progenitor cell (RPC) population in the Ccnd1-/- retina is caused by enhanced cell 
cycle exit. (A-F) Wild-type (wt) and Ccnd1-/- retinas were labeled with an antibody against PCNA from E12 to P0. Dashed 
lines in (A, B, D, E) demarcate the differentiated cell layer (DCL) from the neuroblast layer (NBL). Brackets in (F) show the 
'apical gap' in the P0 mutant retina. (G) Quantification of PCNA+ cells from E12, E14.5 and P0 retinas. (H) Schematic represen-
tation of cell cycle exit assay. (I-N) Wild-type and Ccnd1-/- retina samples, collected at 24 h following a single bromodeoxyuri-
dine (BrdU) injection at E13.5, were co-labeled with antibodies against PCNA and BrdU to measure rate of cell cycle exit, as 
outlined in (H). Arrowheads in (I-N) indicate cells that had exited the cell cycle in the last 24 h. (O) Quantification of exited 
cells (BrdU+, PCNA-) as a percentage of BrdU+ cells at E14 and P0.5. Abbreviations: DCL, differentiated cell layer; L, lens; NBL; 
neuroblast layer NR; neural retina. Scale bars: 100 m; (E) is representative for (B, E); (F) for (A, C, D, F); (N) for (I-N).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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The proportions of horizontal and amacrine cells are 
reduced in the Ccnd1-/- retina, despite increased cell cycle 
exit
Since the decrease in the relative proportion of the RPC
population correlates with increased neurogenesis in the
embryonic Ccnd1-/- retina, it stands to reason that the pro-
portions of other early-born cell types, such as horizontal
and amacrine cells, would also be increased. We found,
however, that these cell types are in fact underrepresented
at E17.5 (data not shown) and P0 (Figure 6). Horizontal
cells, which express NEFM, are positioned in a single line
towards the outer part of the NBL (Figure 6A, arrows). In
the Ccnd1-/- retina, these cells are spaced further apart, and
displaced toward the IPL (Figure 6C, arrows). This reduc-
tion in horizontal cells is clearly indicated in retinal whole
mounts (Figure 6B, D), by quantification of their lineal
density on retinal sections (Figure 6E), and with other
markers of horizontal cells (aquaporin 4, prox1, and cal-
bindin; data not shown). We also observed a distinct
reduction in a subpopulation of amacrine cells marked by
SOX2 and islet1 (ISL1) co-expression (Figure 6F–L) [38].
Whereas SOX2+, ISL1+ cells appear as an orderly bi-layer
on both sides of the IPL (Figure 6F–H), the cells posi-
tioned below the IPL are mostly absent in the Ccnd1-/- ret-
Retinal ganglion cells (RGCs) are overproduced in the Ccnd1-/- retina Figure 4
Retinal ganglion cells (RGCs) are overproduced in the Ccnd1-/- retina. (A-H) Wild-type (wt) and Ccnd1-/- retinas were 
stained with an antibody against POU4F2, which marks a majority of RGCs, at E11, E12, E14.5 and P0. Arrows in (H) mark the 
extra layer of RGCs in the Ccnd1-/- retina at P0. (I) Quantification of relative proportions of POU4F2+ RGCs. (J) Quantification 
of relative rate of POU4F2+ RGC production between E13.5 to E14.5. Abbreviations: DCL, differentiated cell layer; L, lens; 
NBL, neuroblast layer; NR, neural retina. Scale bars: 100 m; (G) is representative for (C, G); (H) for (A, B, D, E, F, H).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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ina and the remaining cells are spaced further apart
(Figure 6I–K).
Ccnd1 deficiency has different effects on distinct 
precursor populations
Although our analysis of apoptosis (Additional file 2 and
data not shown) suggests that cell death is not contribut-
ing to the embryonic phenotype, we cannot entirely rule
it out as a factor in causing the reduction in horizontal
cells and SOX2+, ISL1+ amacrine cells as these cell types
are normally in low abundance. Furthermore, as it is hard
to discern NEFM+ horizontal cells during early neurogen-
esis and SOX2 expression is indicative of advanced stages
of maturation, the reductions in these markers could also
be due to delayed differentiation. This is unlikely, how-
ever, as cells expressing these markers continue to appear
reduced at later ages (data not shown). Another possibil-
ity is that the Ccnd1 deficiency is causing an underproduc-
tion in the post-mitotic precursors from which these
particular cell types arise. To address this, we examined
retinas at earlier stages of development using markers
expressed in newly generated precursors of horizontal,
amacrine, and photoreceptor cells (Figure 7). Pancreas
specific transcription factor, 1a (Ptf1a) encodes a basic
helix-loop-helix transcription factor expressed in horizon-
tal cell precursors and a subset of amacrine cell precursors
[39-41]. Basic helix-loop-helix family, member e22
(Bhlhe22, henceforth referred to as Bhlhb5) is another
Proportion of photoreceptor cells is increased in the Ccnd1-/- retina Figure 5
Proportion of photoreceptor cells is increased in the Ccnd1-/- retina. Expression pattern of cone precursor marker 
(A, D) RXR, (B, E) rod precursor marker NR2E3, and (C, F) general photoreceptor marker RCVRN at P0. (G-I) Quantifi-
cation of relative proportions of RXR+, NR2E3+ RCVRN+ cells, respectively, at P0. Abbreviations: NR, neural retina. Scale 
bars: 100 m (D) is representative for (A, D); (E) for (B, E); (F) for (C, F).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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basic helix-loop-helix factor expressed in embryonic pre-
cursors that give rise to GABAergic and displaced amacrine
cells [42]. Otx2 is predominantly expressed in photore-
ceptor precursors, although a subset of RGC and amacrine
precursors transiently express Otx2 at the start of their dif-
ferentiation [43-45].
Whereas a few cells in the E12 wild-type dorsal retina
express PTF1A, significantly fewer PTF1A+  cells are
detected in the Ccnd1-/- retina (Figure 7A, D, G). In con-
trast, BHLHB5+ cells, which are more abundant at this age,
do not differ in their relative proportions between the
wild-type and Ccnd1-/- retina (Figure 7B, E, G). OTX2
expression is evident in the retinal pigmented epithelium,
peripheral retina, and isolated cells in the NBL (Figure 7C,
F) and quantification of OTX2+ cells in the NBL reveals a
decrease in their proportion in the Ccnd1-/- retina (Figure
7G). This decrease is also reflected in RXR immunoreac-
tivity (data not shown), which suggests a drop in cone
precursor production at this age. At E14.5, the general
trends for each marker are similar to that found at E12
(Figure 7H–N), but it appears that the proportion of
OTX2+ cells is catching up in the mutant (Figure 7N). At
P0, the proportion of PTF1A+ cells remains reduced in the
Reduced densities of horizontal and amacrine cells in the Ccnd1-/- retina Figure 6
Reduced densities of horizontal and amacrine cells in the Ccnd1-/- retina. (A, C) Expression pattern of NEFM at P0 is 
shown. Arrows point to representative horizontal cells. Bright staining in the differentiated cell layer (DCL) is due to NEFM 
expression in retinal ganglion cells (RGCs). (B, D) Retinal whole mounts stained with NEFM antibody reveal differences in 
horizontal cell density across retina. Tissues were imaged from basal surface to reduce interference from NEFM immunoreac-
tivity in RGCs. Insets show boxed regions. (E) Quantification of NEFM+ horizontal cells at P0. (F-K) Expression patterns of 
SOX2 (F, I) and ISL1 (G, J) at P0 (merged images in (H, K)) are shown. (L) Quantification of SOX2+, ISL1B+ amacrine cells at 
P0. Abbreviations: DCL, differentiated cell layer; NBL; neuroblast layer. Scale bars: 100 m; (C) is representative for (A, C); 
(D) for (B, D).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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Ccnd1-/- retina (Figure 7O, R, U) and the relative propor-
tion of Bhlhb5+ cells does not differ between the wild-type
and Ccnd1-/- retina (Figure 7U), although their distribu-
tion is altered (Figure 7P, U). The relative proportion of
OTX2+ cells in the Ccnd1-/- retina is greater than in wild-
type at P0 (Figure 7Q, T, U) and the larger proportions of
RCVRN+, NR2E3+, and RXR+ cells (Figure 5) collectively
support the idea that, by P0, rod and cone precursor pro-
duction is enhanced in the absence of Ccnd1.
To gain insight into the potential relationships between
these precursor populations, we directly compared the
Ccnd1-deficiency causes alterations in the proportions of precursor cell populations Figure 7
Ccnd1-deficiency causes alterations in the proportions of precursor cell populations. Expression patterns of (A, D, 
H, K, O, R) PTF1A, (B, C, I, L, P, S) BHLHB5 and (C, F, J, M, Q, T) OTX2 at E12 (A-F), E14.5 (H-M), and P0 (O-T) are 
shown. (G, N, U) Quantification of marker+ cells at E12 (G), E14.5 (N), and P0 (U). Abbreviations: DCL, differentiated cell 
layer; NBL, neuroblast layer; PR, peripheral retina; RPE, retinal pigmented epithelium. Scale bar: 100 m; (F) is representative 
for (A-F); (M) for (H-M); (T) for (O-T).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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expression patterns of PTF1A, BHLHB5, and OTX2 at E12,
E14.5 and P0 (Figure 8). Regardless of age, PTF1A is not
expressed in the same cells as BHLHB5 or OTX2, which
suggests that PTF1A+  precursors are distinct from
BHLHB5+ precursors (Figure 8A, D, G, J, M, P) and OTX2+
precursors (Figure 8B, E, H, K, N, Q). In contrast, OTX2
and BHLHB5 are co-expressed in a subset of cells from
both populations (Figure 8C, F, I, L, O, R, arrowheads). At
E12, cells co-expressing OTX2 and BHLHB5 persist in the
Ccnd1-/- retina even though OTX2+ cells are fewer (Figure
8C, F). At E14.5 and P0, the majority of cells co-expressing
BHLHB5 and OTX2 are found in the NBL and not in the
apical layer of OTX2+  cells (Figure 8I, O), which are
instead marked by RXR or NR2E3 (data not shown), and
these relationships are maintained in the Ccnd1-/- retina
(Figure 8L, R; data not shown). These observations suggest
that the combinatorial expression of OTX2 and BHLHB5
marks multiple precursor populations. In sum, although
we cannot definitively rule out apoptosis or altered differ-
entiation as contributing factors, these data strongly sug-
gest that Ccnd1  inactivation alters the production of
specific cell populations from the earliest times after onset
of neurogenesis by altering the relative output of precur-
sor cells from RPCs.
Ccnd2 cannot completely rescue the Ccnd1-/- retinal 
phenotype
Genetic replacement of Ccnd1  by  Ccnd2  in  Ccnd1D2/D2
knock-in mice restores the histological appearance of the
adult retina and electroretinographic response of photore-
ceptors [22]. In this model, the Ccnd2 cDNA sequence is
inserted into the Ccnd1 locus and regulated by the Ccnd1
promoter and enhancer elements. We examined the P0
retina in these mice to determine if Ccnd2 is sufficient to
correct the developmental changes due to Ccnd1  defi-
ciency (Figure 9). PCNA immunolabeling reveals that,
similar to the Ccnd1-/- retina, the RPC layer is thinner in
the Ccnd1D2/D2 retina compared to its wild-type control,
with a 'gap' at the apical surface (Figure 9A, B; brackets in
B) that is filled with OTX2+ cells (Additional file 5J–L).
Scoring of PCNA+ cells reveals that their proportion is sig-
nificantly reduced (Figure 9E). Unlike the Ccnd1-/- retina,
POU4F2+ cells are not mis-positioned on the apical side of
the IPL layer (Additional file 6E). Quantification of
NEFM+ horizontal cells revealed a significant decrease in
their numbers (Figure 9F, G, J) although not to the same
magnitude as in the Ccnd1-/- retina (Figure 6E). In agree-
ment with this trend, there appear to be fewer PTF1A+,
SOX2+, and BHLHB5+ cells in the Ccnd1D2/D2 retina com-
pared to its wild-type control (Additional file 6B–D, F–H).
These findings indicate that Ccnd2  is not sufficient to
completely compensate for Ccnd1 in retinal cell produc-
tion.
Genetic manipulation of downstream cell cycle regulators 
minimizes the impact of the Ccnd1 deficiency on 
embryonic retinal development
Genetic and biochemical evidence suggests that the rate-
limiting function of Ccnd1 in promoting cell cycle pro-
gression is to stimulate Ccne activity [23]. Based on this
model, the altered cell production in the Ccnd1-/- RPC
population could be due to limited Ccne activity. To
address this, we analyzed the newborn retina in a mouse
strain in which the human Ccne cDNA is inserted into the
Ccnd1  locus. In this strain, referred to as Ccnd1hE/hE,
human Ccne is expressed in place of Ccnd1. Similar to the
Ccnd1D2/D2 mouse, the adult retina in this model appears
histologically normal and electrophysiological properties
are better than in the Ccnd1-/- retina [23].
Our initial analysis revealed that the Ccnd1hE/hE retina is
thinner than its wild-type counterpart, which may be due
to an increase in apoptosis, especially in the NBL (Figure
9K–N). In contrast to the Ccnd1-/- and Ccnd1D2/D2 retinas,
PCNA staining shows that the RPC layer extends all the
way to the apical edge, similar to the wild-type control
(Figure 9C, D). Whereas the proportions of PCNA+ and
NEFM+  cell populations are not significantly different
from wild type, they exhibit downward trends (Figure 9E,
H, I, J). The relative proportions and positions of cells
expressing POU4F2, PTF1A, SOX2, and BHLHB5 appear
to be similar between the Ccnd1hE/hE and its wild-type con-
trol retina (Additional file 6I–P). These findings suggest
that Ccne is more efficient than Ccnd2 in replacing Ccnd1
to control the balance of retinal cell types produced.
The sequestration of P27KIP1 by CCND1 protein is one
mechanism by which CCND1 is predicted to enhance
CCNE activity and promote cell cycle progression [11].
Consistent with this, genetic inactivation of p27Kip1 alle-
viates many of the phenotypes seen in the Ccnd1-/- mouse
[46,47]. Furthermore, ectopic proliferation occurs in the
p27Kip1-/- retina and its overexpression inhibits RPC pro-
liferation [48,50]. To test whether the removal of p27Kip1
restores the balance of cell types in the absence of Ccnd1,
we analyzed Ccnd1-/-, p27Kip1-/- double mutant retinas at
P0 (Additional file 7). We found that the expression pat-
tern of PCNA in the double mutant retina is more similar
to the control retina (Ccnd1+/-) than to the Ccnd1-/- retina,
which is indicated by the absence of an 'apical gap' in
staining (Additional file 7A, G, S). The cellular distribu-
tions of POU4F2+ RGCs, NEFM+ horizontal cells as well as
other cell populations expressing PTF1A, SOX2, and
BHLHB5 in the double mutant also appear more similar
to the control patterns than those in the Ccnd1-/- retina
(Additional file 7B–F, H–L, T–X). For comparative pur-
poses, the expression patterns for these markers in the
p27Kip1-/- retina are shown in Additional file 7M–R. The
sum of our observations from the Ccnd1hE/hE and Ccnd1-/-,Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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p27Kip1-/- mice suggest that Ccnd1's influence on precur-
sor cell output is dependent on its role in regulating Ccne
and p27Kip1.
Discussion
We report here that Ccnd1 has important functions in reg-
ulating embryonic retinal histogenesis. In addition to
hypocellularity due to changes in proliferation, the rela-
tive proportions of multiple post-mitotic precursor popu-
Relationship between PTF1A+, BHLHB5+, and OTX2+ precursors Figure 8
Relationship between PTF1A+, BHLHB5+, and OTX2+ precursors. Retinal sections at (A-F) E12, (G-L) E14.5, and 
(M-R) P0 were double-labeled with combinations of antibodies against PTF1A, BHLHB5 and OTX2. Arrowheads in (C, F, I, L, 
O, R) show examples of cell co-expressing OTX2 and BHLHB5. Arrows in (B, C, E, F, H, I, K, L) point to the retinal pigmented 
epithelium (RPE). Abbreviations: DCL, differentiated cell layer; NBL, neuroblast layer; RPE, retinal pigmented epithelium; wt, 
wild type. Scale bar: 100 m; (R) is representative for all panels.Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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lations are altered in the Ccnd1-/- retina. RGC precursors
are overrepresented, and horizontal cell and a subset of
amacrine cell precursors are underrepresented in the
Ccnd1-/- retina relative to wild type. Photoreceptor precur-
sors, while underrepresented early on, are overrepresented
later. Since overall cell number is lower in the mutant ret-
ina [21], our data suggest that the initial reduction in pho-
toreceptor precursors and the apparent permanent
reduction in horizontal and amacrine cell precursors
reveals a true reduction in their numbers compared to
wild type. While it is not known if the absolute number of
RGCs and photoreceptors differs from wild type, our data
show that their relative contributions to the cell composi-
tion of the Ccnd1-/- retina is greater than in wild type.
Analysis of Ccnd1D2/D2 and Ccnd1hE/hE retinas at P0 Figure 9
Analysis of Ccnd1D2/D2 and Ccnd1hE/hE retinas at P0. (A-D) Expression pattern of PCNA) in Ccnd1D2/D2 retina (B), Ccnd1hE/
hE retina (D) and their respective wild-type (wt) controls (A, C) is shown. (E) Quantification of proportions of PCNA+ cells. 
(F-I) Expression pattern of NEFM in Ccnd1D2/D2 retina (G), Ccnd1hE/hE retina (I) and their respective wild-type controls (F, H) is 
shown. (J) Quantification of NEFM+ cells. (K, L) TUNEL labeling in wild-type (K) and Ccnd1hE/hE retina (L). (M, N) Activated 
CASP3 immunoreactivity in wild-type (M) and Ccnd1hE/hE retina (N). Brackets in (B) show the 'apical gap' in the P0 Ccnd1D2/D2 
retina. Abbreviations: NR, neural retina. Scale bar: 100 m (N is representative for all panels).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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The changes outlined above are likely to be the result of
Ccnd1's roles in the cell cycle. Since cell cycle transit time
is longer and the relative rate of cell cycle exit is enhanced
in the absence of Ccnd1, it is possible that these changes
in proliferation are linked. While longer cell cycle times
are predictive of increased cell cycle exit in the brain
[ 5 1 , 5 2 ] ,  t h i s  d o e s  n o t  a p p e a r  t o  b e  t h e  c a s e  i n  t h e
zebrafish retina [53,54]. So whether the lengthening of
the cell cycle directly causes enhanced cell cycle exit in the
Ccnd1-/- retina is not clear. Regardless, we propose that
Ccnd1 is required for establishing the proper balance of
cell types produced during embryonic retinal develop-
ment by mediating cell cycle exit, or in other words, the
rate of precursor output from RPCs.
Ccnd1 regulates the timing of cell cycle exit in a limited 
manner after the onset of neurogenesis
Interestingly, not all Ccnd1-/- RPCs exit prematurely, and
the extent of RPC depletion, while significant, is not
severe. A reasonable percentage of Ccnd1-/- RPCs remain in
the cell cycle even as neurogenesis progresses. This is not
due to restricted expression as Ccnd1 is widely expressed
in RPCs and throughout most of the cell cycle (this study)
[15,18]. Rather, D-cyclins are not absolutely required for
proliferation in embryonic RPCs since proliferation still
occurs in mice deficient in Ccnd1, Ccnd2, and Ccnd3 [14].
We also found no evidence that Ccnd1-/- RPCs exit the cell
cycle before the normal onset of neurogenesis even
though Ccnd1 is abundantly expressed as early as E9.5.
This is not because RPCs are inherently unable to initiate
neurogenesis early since precocious neurons are produced
in the paired box gene 6 (Pax6-/-) and hairy and enhancer
of split 1 (Hes1-/-) retinas [55,57]. Furthermore, the
spreading wave of neurogenesis is not altered in the
Ccnd1-/- retina, even though wild-type RPCs increase their
level of CCND1 expression just ahead of the neurogenic
wave. These observations led us to propose a model stat-
ing that once neurogenesis begins, a limited number of
RPCs become Ccnd1-dependent and their timing of cell
cycle exit is determined by their level of CCND1 expres-
sion or activity (Figure 10A). We also predict that Ccnd1-
dependent RPCs are generated continuously during reti-
nal development and have limited proliferative potential.
Otherwise, Ccnd1 deficiency should have caused a more
discontinuous or severe decline in the RPC population. It
appears then that downregulation of Ccnd1 is an impor-
tant step in the transition of RPCs to post-mitotic precur-
sors. Consistent with this, forced expression of CCND1 in
photoreceptor precursors causes unscheduled prolifera-
tion, differentiation defects, and apoptosis [58].
Mechanism of Ccnd1-mediated cell cycle exit
D-cyclins regulate the retinoblastoma pathway by binding
to and activating CDK4/6 and by sequestering CDK2
inhibitors such as P27KIP1 [11]. Both mechanisms ulti-
mately lead to inactivation of retinoblastoma proteins by
CDK2/4/6-mediated phosphorylation, allowing cells to
progress from G1 to S phase and undergo DNA replica-
tion. Although the importance of the retinoblastoma
pathway in continuously cycling cells is not clear, it is crit-
ical in many cell lineages for differentiation [59-61]. In
the mouse retina, genetic deletion of the retinoblastoma
proteins (Rb1, Rbl1/p107, or Rbl2/p130) uncouples cell
cycle exit and differentiation, resulting in ectopic prolifer-
ating cells that express markers of multiple precursor cell
types in the retina [62,65]. Further evidence of this decou-
pling is seen in the postnatal p107 single copy mutant ret-
ina where mature horizontal cells proliferate extensively,
all the while retaining their differentiated characteristics
[66]. This suggests that retinoblastoma pathway activity
regulates cell cycle exit of RPCs and controls the post-
mitotic state for some period of time after cell cycle exit.
Additional evidence to this effect comes from genetic
studies of molecular regulators in this pathway: inactiva-
tion of cyclin-dependent kinase inhibitors such as
p27Kip1, p57Kip2, and p19Ink4d cause ectopic prolifera-
tion [9,48,50,67]. Forced expression of Ccnd1, the large T-
antigen from simian virus 40 or the human papillomavi-
rus type 16 (HPV-16) E7 protein (negative regulators of
retinoblastoma proteins) in post-mitotic photoreceptor
precursors causes inappropriate cell cycle re-entry and
subsequent cell death or tumorigenesis depending on the
nature of the transgene construct [58,68-72]. A similar
phenomenon is also observed for other retinal cell types
[73,75]. Furthermore, Rb1  phosphorylation is greatly
diminished in the Ccnd1-/- retina, probably due to reduc-
tions in CDK2 and CDK4 activities [23,46,47,76]. Since
the retinoblastoma proteins are expressed in dynamic and
temporal patterns in mouse RPCs [60,64,77], their expres-
sion levels in individual RPCs may determine the timing
of  Ccnd1-dependence (Figure 10A). However, other
mechanisms such as extracellular signaling are also likely
to contribute to tempering retinoblastoma protein activity
in continuously cycling RPCs [12].
Our results indicate that Ccnd2 may not influence RPC
cell cycle exit in the same manner as Ccnd1. Although the
retina in the Ccnd1D2/D2 mouse is not as severely affected
as in the Ccnd1-/- mouse, cell production is not restored to
normal proportions. Limited Ccnd2 expression is not the
likely reason for this [22]. Rather, molecular analyses indi-
cate that CCND2 activity is not identical to CCND1
[22,46,47,78]. The newborn Ccnd1hE/hE retina also has a
more normal cellular composition than the Ccnd1-/- retina
and may surpass the extent of rescue in the Ccnd1D2/D2 ret-
ina. Interpretation of the phenotype is complicated by
enhanced cell death, which is not observed in the new-
born Ccnd1-/- or Ccnd1D2/D2 retinas. This is probably due
to high hCcne expression as endogenous Ccne is normally
expressed at low levels [18] (unpublished observations).Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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Models of Ccnd1 function in the retina Figure 10
Models of Ccnd1 function in the retina. (A) General model of Ccnd1-dependence in retinal progenitor cells (RPCs). Most, 
if not all RPCs express CCND1. At least one division before cell cycle exit, RPCs become dependent on CCND1 to remain in 
the cell cycle (RPCs in gray box). Those that retain sufficiently high Ccnd1 levels or activity continue to divide whereas those 
that drop below a threshold will produce at least one post-mitotic precursor cell (P). It is not known if the other daughters of 
each division are Ccnd1-dependent, nor is the mode of division known for Ccnd1-dependent RPCs. It is presumed that at least 
some of the RPCs that persist contribute to the RPC population at later stages. (B) Model of how cell production is altered in 
the absence of Ccnd1 during early retinal development. In the wild-type retina, a proportion of CCND1-dependent RPCs will 
produce precursors that differentiate into cone, horizontal, or amacrine cells (O/P). In the Ccnd1-/- retina, Ccnd1-dependent 
RPCs exit at least one division sooner, resulting in a gradual reduction in the size of the RPC population and an enhancement 
in the relative production of retinal ganglion cell (RGC) precursors at the expense of other precursor types. This could be due 
to an instructive role for Ccnd1 in cell fate specification or to a consequence of RPC competence and/or altered environment 
at the time of exit. The inability of RPCs to replenish the PTF1A precursor population (as it does for the OTX2 precursor pop-
ulation) suggests that most RPCs lose their competence to make PTF1A precursors (R*). Similar mechanisms may influence the 
output of other precursor populations.Neural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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While hCcne may rescue premature cell cycle exit due to
the Ccnd1 deficiency, it could also activate apoptosis by
causing an incompatible activation of proliferation and
differentiation pathways in precursor cells. Nevertheless,
instead of functionally replacing Ccnd1, ectopically
expressed hCCNE bypasses the retinoblastoma proteins
[23], by partnering with CDK2 to induce S-phase entry
without sufficient RB1 phosphorylation [79]. A similar
bypass mechanism appears to be operating in the Ccnd1-/
-, p27Kip1-/- retina [46,47] and the more normal distribu-
tion of cell types in the newborn Ccnd1-/-, p27Kip1-/- retina
at P0 supports the idea that p27Kip1 is downstream of
Ccnd1 in regulating the production of precursor popula-
tions. The sum of these findings agrees with the model
that  Ccnd1-mediated regulation of the retinoblastoma
pathway is an important mechanism for controlling the
timing of cell cycle exit in embryonic RPCs.
Ccnd1 influences the production of precursor cells 
allocated to multiple cell types
In multipotential progenitor cell lineages, enhanced rates
of cell cycle exit tend to cause reductions in late-born cell
types that may or may not be accompanied by increases in
the production of early-born cell types [55,57,80-83].
Interestingly, the changes in cell production that occur in
the embryonic Ccnd1-/- retina diverge from this general
rule. RGC production is enhanced whereas unexpectedly,
production of other early-born cell types, namely hori-
zontal cells, SOX2+, ISL1+ amacrine cells, and cones (ini-
tially), is reduced, and these types of alterations are
indicative of changes in cell fate specification (Figure
10B). Since Ccnd1 is expressed in RPCs and not in post-
mitotic precursors, how might Ccnd1  inactivation pro-
duce these changes?
One possibility is that Ccnd1 has an instructive role in ret-
inal cell fate determination, similar to Ccne in the thoracic
NB6-4 neuroblast lineage in Drosophila [84]. Ccnd1 may
prevent a subset of early neurogenic RPCs from becoming
RGCs by directing them toward horizontal, amacrine, or
cone cell fates. Indeed, production of PTF1A+ precursors is
reduced in the Ccnd1-/-retina, and Ptf1a  inactivation
results in a cell fate switch from horizontal and amacrine
cells to RGCs [39-41]. Although OTx2+ (and RXR+) pre-
cursors are also underrepresented in the Ccnd1-/- retina at
E12 and E14.5, it is unclear how Ccnd1 could instruct
photoreceptor fate since inactivation of OTx2 in photore-
ceptor precursors causes conspicuous amacrine cell over-
production and apoptosis by P0 [45], two changes not
observed in the Ccnd1-/- retina. Regardless, if Ccnd1  is
instructive for cell fate, we predict that the mechanism
involved could operate independently of its role in timing
RPC cell cycle exit since altering precursor cell fates does
not necessarily involve changes in proliferation.
Another possibility is that Ccnd1 deficiency could produce
cell fate changes that are linked to the altered timing of
cell cycle exit (Figure 10B). In this scenario, an early neu-
rogenic, Ccnd1-dependent RPC is competent to become
an RGC, but is prevented from doing so because it
expresses CCND1 and stays in the cell cycle. As CCND1
levels drop below a threshold in a subsequent cell cycle,
the RPC exits and differentiates into the other early-born
cell types (that is, horizontal, amacrine, cone; O/P precur-
sor in Figure 10B) because of changes in its competence
and/or in its surrounding environmental milieu. In the
absence of CCND1, the Ccnd1-dependent RPC exits at
least one cell cycle sooner and differentiates into an RGC
at the expense of other early-born cell types (Figure 10B).
Attractive features of this model are that it incorporates
current ideas on retinal development: that RPCs are
multipotential; that temporal shifts in RPC competence
occur as development progresses; and that the concerted
actions of cell-extrinsic and -intrinsic pathways mediate
cell fates [85]. Importantly, it doesn't invoke a function
for Ccnd1 beyond controlling the timing of cell cycle exit.
An unresolved issue, however, is that while this model
accounts for enhanced RGC production early and pho-
toreceptor production late, it fails to explain the persistent
underproduction of other early-born cell types in the
mutant. If RPCs are multipotential and premature cell
cycle exit is a continuous and ongoing process in the
Ccnd1-/-  retina, then the RPCs that exit subsequently
should compensate for the earlier exited RPCs and pro-
duce the precursors that are initially underproduced.
While this is observed for the OTX2+, RXR+ precursors
(cones), production of PTF1A+  precursors (horizontal
cells and some amacrine cells) fails to 'catch up'. One pos-
sibility is that most RPCs lose their competence to pro-
duce PTF1A+ precursors (R* in Figure 10B). In the Ccnd1
mutant, the PTF1A-incompent RPCs are unable to com-
pensate for the early underproduction of PTF1A+ precur-
sors; thereby resulting in a permanent deficit in these
precursors and the cell types they give rise to.
The BHLHB5+ cell population is unique in that its propor-
tion does not vary between the wild type in the Ccnd1-/-
retina, at least up to P0. Given the idea that subsets of
RPCs may utilize different proteins to control cell cycle
exit [18], BHLHB5+ precursors may not require Ccnd1 to
regulate the number of RPCs needed for their production.
The fact that the proportion of BHLHB5+  precursors
remains consistent may also be an indication that produc-
tion of this cell population is dependent on non-cell
autonomous feedback signaling [86-88].
As mentioned at the start of this section, a more rapid rate
of RPC depletion due to enhanced neurogenesis should
cause a reduction or absence in the last generated cellNeural Development 2009, 4:15 http://www.neuraldevelopment.com/content/4/1/15
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types. Interestingly, rods, bipolar cells, and Müller glia are
present in the postnatal Ccnd1-/- retina as are PCNA+ cells
[21] (unpublished observations), which indicates that
RPCs persist until the last stages of normal histogenesis.
This could occur if our model of Ccnd1-dependence in
embryonic RPCs also holds for postnatal RPCs. If true,
then the rate of RPC decline may not be steep enough to
deplete the population prior to production of the last-
born cell types, although again, we would expect a drop in
their numbers. Our observation of an increased propor-
tion of rod precursors at P0 suggests that they are being
produced at the expense of bipolar cells and Müller glia,
similar to what may be happening for RGC precursors and
the other early-generated precursor populations. Assess-
ing this is difficult, however, because of the extensive cell
death in the postnatal Ccnd1-/- retina, when bipolar cells
and Müller glia are being produced [21,89]. Alternatively,
RPCs in the postnatal period may not require Ccnd1 to
control timing of cell cycle exit, and one possible explana-
tion is that Ccnd3 takes over, a scenario analogous to D-
cyclin utilization in cerebellar granule precursors, which
depend on Ccnd1 early and Ccnd2 late, to produce the cor-
rect number of granule cells [82,90]. Ccnd3 is normally
expressed in Müller glia and possibly in RPCs at the end
of histogenesis (that is, P5 and older). Importantly,
CCND3 expression is upregulated by P0 in the Ccnd1-/-
retina (unpublished observation) [47], which suggests a
possible compensatory mechanism for maintaining post-
natal RPCs.
Does Ccnd1 regulate laminar positioning of retinal cells?
Retinal cells occupy distinct locations in the retina and
cells of the same cell type generally occupy the same lam-
inar position. Unexpectedly, we found that the locations
of cells belonging to several different classes are altered in
the Ccnd1-/- retina. For example, RGCs are distributed on
both sides of the IPL and horizontal cells are positioned
closer than normal to the IPL. Why this occurs is not clear,
but  Ccnd1  can influence cell migration via the ROCK
pathway [91,92]. Important to note, however, is that hor-
izontal cells briefly reside in this position during their
normal course of differentiation [93,94]. Whether Ccnd1
has a direct role in regulating precursor cell positioning/
migration or if these changes are due to indirect effects of
altered differentiation or because of compromised cell-
cell interactions due to the changes in the proportions of
retinal cell types awaits further analysis.
Conclusion
This study elucidates the roles of Ccnd1 in embryonic ret-
inal development. We show that Ccnd1 is expressed glo-
bally in RPCs and contributes to two aspects of
proliferation control – the rate of cell cycle progression
and the timing of cell cycle exit. Ccnd1 is also required to
ensure that precursor populations are produced in their
appropriate proportions. We propose that Ccnd1 does this
through its control of cell cycle exit and that the perma-
nent reduction in the PTF1A+ precursor population in the
Ccnd1-/- retina is the result of a temporal shift in RPC com-
petence. More studies are needed to address whether
Ccnd1 also has a direct role in regulating precursor fates
and, if so, whether p27Kip1 or other cell cycle regulators
that are downstream of Ccnd1 are involved. This work
provides further evidence for the model that cell cycle reg-
ulators contribute to the neurogenic output of multipo-
tential progenitor populations.
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